In the FST and the EZMT, co-administration of OXT (0.5 μg) with OXTRA (1 μg) into the CeA did not rescue isolation-induced depression and anxiety-related behaviors in the FST and the EZMT, respectively (Figures 3A,B). Here, OXT is linked to major depressive disorder.